4.6 Article Proceedings Paper

Increasing Use of the Right Ventricle-to-Pulmonary Artery Shunt for Stage 1 Palliation

Journal

ANNALS OF THORACIC SURGERY
Volume 115, Issue 5, Pages 1229-1236

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.athoracsur.2021.12.040

Keywords

-

Ask authors/readers for more resources

This study evaluated the trends and factors influencing the first-stage palliation for hypoplastic left heart syndrome. It found that the use of right ventricle-to-pulmonary artery shunt increased over time, while the use of modified Blalock-Taussig shunt decreased. Higher-volume centers, male patients, and less complex patients were more likely to receive modified Blalock-Taussig shunt. However, compared to the right ventricle-to-pulmonary artery shunt, the modified Blalock-Taussig shunt was associated with higher mortality/transplant rates before the second-stage palliation.
BACKGROUND Stage 1 palliation of hypoplastic left heart syndrome entails use of the Norwood operation with a modified Blalock-Taussig shunt or a right ventricle-to-pulmonary artery shunt, or the hybrid procedure. Use trends and factors influencing palliation selection remain unclear. We aimed to evaluate these questions and to compare outcomes between types of stage 1 palliation. METHODS The National Pediatric Cardiology Quality Improvement Collaborative phase 1 (June 2008-August 2016) and phase 2 (August 2016-September 2019) databases were used. Procedure type was assessed by operation year. Baseline characteristics and annual hospital volume were evaluated. Postsurgical admission duration and outcomes were compared. RESULTS A total of 3497 patients were included, 30.8% with modified Blalock-Taussig shunt, 59.7% with right ventricle-to-pulmonary artery shunt, and 9.5% with hybrid. Use of the right ventricle-to-pulmonary artery shunt increased over time (P = .02). This increase was similar among all hospital volumes. Higher hospital volume (odds ratio [OR], 1.2; 95% CI, 1.1-1.4; P = .003), male sex (OR, 1.3; 95% CI, 1.1-1.6; P = .01), and isolated cardiac disease (OR, 1.33; 95% CI, 1.01-1.55; P = .05) were associated with relatively higher likelihoods of a modified Blalock-Taussig shunt. Mortality/transplant rates before stage 2 palliation were higher with the modified Blalock-Taussig shunt than with the right ventricle-to-pulmonary artery shunt (12.3% vs 9.6%, P = .03). CONCLUSIONS In stage 1 palliation, use of right ventricle-to-pulmonary artery shunts has increased over time, use of modified Blalock-Taussig shunts has decreased, and use of hybrids was unchanged. The modified Blalock-Taussig shunt has a higher likelihood of use in higher-volume centers, males, and less complex patients but is associated with longer hospitalizations and lower transplant-free survival to stage 2 palliation. (Ann Thorac Surg 2023;115:1229-37) (c) 2023 by The Society of Thoracic Surgeons

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available